Member Services
memberservices@aan.com
(800) 879-1960
(612) 928-6000
FDA Approves Botox to Treat Urinary Incontinence in People with Neurological Conditions Including Multiple Sclerosis and Spinal Cord Injury
August 25, 2011
email to a friend |
print |
Post a comment
| Login to rate this article
Share:
The U.S. Food and Drug Administration approves Botox (onabotulinumtoxinA) injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder.
Member Comments (0 comments)
Disclaimer: The opinions expressed in this posting are those of the author only and do not represent the views of the American Academy of Neurology or any of its affiliated subsidiaries.
Please login to view and submit comments.
For More Information
Related Communities
Advertisement
Advertisement